Territory Stories

NT drug trends 2005 : findings from the Illicit Drug Reporting System (IDRS)



NT drug trends 2005 : findings from the Illicit Drug Reporting System (IDRS)


Northern Territory drug trends; E-Journals; PublicationNT; NDARC technical report ; no. 243




Made available via the Publications (Legal Deposit) Act 2004 (NT).; This publication contains may contain links to external sites. These external sites may no longer be active.






Drug abuse -- Northern Territory -- Statistics -- Periodicals; Drug abuse -- Northern Territory -- Periodicals; Drug abuse surveys -- Northern Territory -- Periodicals

Publisher name

National Drug and Alcohol Research Centre, University of New South Wales

Place of publication



NDARC technical report ; no. 243



Copyright owner

Check within Publication or with content Publisher.

Parent handle


Citation address


Page content

50 Table 35: Frequency of morphine use in previous 6 months, % IDU, 2003-2005 2003 (n=87) 2004 (n=94) 2005 (n=86) % fortnightly 90 86 88 % weekly 86 83 80 % daily 56 48 47 Source: IDRS IDU interviews Form Table 36 details the forms of morphine used in the past six months. The proportions using licit and illicit morphine this year more closely reflect those found in 2003. Since last year there was a 1% increase in those using licit morphine (now 30%) and a decrease of 10% in those using illicit morphine (now 70%). Twenty-six percent (26%) would use licit morphine most often and 54% would use illicit morphine most often. MS Contin remains the most popular brand of morphine used; however, proportions have decreased slightly this year and this is compensated by an increase in those using Kapanol (13%). Table 36: Forms of morphine used previous six months and brand, % IDU, 2003-2005 2003 (n=109) 2004 (n=111) 2005 (n=107) Used Most often Used Most often Used Most often Licit 35 28 29 23 30 26 Illicit 73 56 80 62 70 54 Brand MS Contin 72 70 62 Kapanol 5 8 13 Anamorph 3 3 3 Other/generic 4 5 1 Source: IDRS IDU interviews The number of 100mg doses of both MS Contin and Kapanol dispensed through community pharmacies is shown in Figure 37. The figure shows that after the initial decline in the number of MS Contin tablets prescribed from 1999 to 2001, prescription have since remained stable, even after the S8 restrictions in the latter half of 2004. Kapanol capsules, on the other hand, appear to have gradually increased since 1998, although MS Contin prescription are still double that of Kapanol.

Aboriginal and Torres Strait Islander people are advised that this website may contain the names, voices and images of people who have died, as well as other culturally sensitive content. Please be aware that some collection items may use outdated phrases or words which reflect the attitude of the creator at the time, and are now considered offensive.

We use temporary cookies on this site to provide functionality.
By continuing to use this site without changing your settings, you consent to our use of cookies.